New Drug Class for Prurigo Nodularis Moving Forward
AMSTERDAM — Prurigo nodularis (PN), an itchy, highly symptomatic disease that can cause severe impairments in quality of life, may ...
AMSTERDAM — Prurigo nodularis (PN), an itchy, highly symptomatic disease that can cause severe impairments in quality of life, may ...
The Nobel Prize in Physiology or Medicine 2024 has been awarded to US scientists Victor Ambros and Gary Ruvkun for ...
TOPLINE:A higher rate of weight loss within 1 year of initiating orlistat is associated with lower risks for incident gout ...
TOPLINE:Older adults with antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis face a higher risk for end-stage renal disease or mortality and severe ...
New data from the Centers for Disease Control and Prevention (CDC) show significant spikes in pertussis cases compared to last ...
On October 2, the US Food and Drug Administration (FDA)'s Drug Shortage Database showed that the tirzepatide injection (Zepbound, Mounjaro/Lilly) ...
TOPLINE:Crisugabalin — an oral calcium channel alpha 2 delta-1 subunit ligand — was safe and well-tolerated at doses of 40 ...
TOPLINE:Eczematous dermatitis, folliculitis, and seborrheic dermatitis were the most common skin conditions in patients with Down syndrome (DS) in a ...
COPENHAGEN — Serum glial fibrillary acidic protein (sGFAP) is quickly maturing as a biomarker to predict disability in patients with ...
FamilyCatherine Coyne died at home in 2008 at the age of 51A woman who was treated by jailed breast surgeon ...
Nearly 90% of babies who had to be hospitalized with COVID-19 had mothers who didn't get the vaccine while they ...
© 2022 NewsHealth.
© 2022 NewsHealth.